MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-01-0028364
Biostem Pharma Private Limited
Biostem Pharma Private Limited - pharma in Shahabad Markanda, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.65 Cr
▲ 15% YoY
Net profit · FY 2025
₹3.28 Lakh
Net margin 2%
EBITDA · FY 2025
₹7.81 Lakh
EBITDA margin 4.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹13.5 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Biostem Pharma Private Limited
Data last updated:
Biostem Pharma Private Limited is a private limited company based in Shahabad Markanda, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290HR2019PTC078557. Its GSTIN is 06AAICB2838G1ZR (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Inder Jeet Singh and Aman Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 90 Sector – 1 HUDA, Shahabad Markanda, Haryana, India – 136135.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.65 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹3.28 Lakh (net margin 2%) and EBITDA of ₹7.81 Lakh (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 40% over five years.
As per MCA filings, the company has open charges of ₹13.5 Lakh on record.
Biostem Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0028364). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290HR2019PTC078557
Registration Number 078557
Incorporation Date 14 February 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-01-0028364
Key People
Inder Jeet Singh Director Aman Bansal Director Recognitions & Rankings of Biostem Pharma
Contact details
Biostem Pharma Private Limited's registered office is in Shahabad Markanda, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. 90 Sector – 1 HUDA, Shahabad Markanda, Haryana, India – 136135
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biostem Pharma Private Limited, buy the company report.
Comprehensive company report
Biostem Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Biostem Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biostem Pharma Private Limited, buy the company report.
Financials of Biostem Pharma Private Limited
FY 2025 filings availableBiostem Pharma Private Limited reported revenue of ₹1.65 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹1.65 Cr ▲ 15%
Net profit · FY 2025
₹3.28 Lakh margin 2%
EBITDA · FY 2025
₹7.81 Lakh margin 4.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 8%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 117%
5 years · compounded
▲ 41%
Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 15% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biostem Pharma Private Limited, buy the company report.
Board of directors of Biostem Pharma Private Limited
Biostem Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Inder Jeet Singh Also directs: Orange Biotech Private Limited, Bioversal Remedies Private Limited, Saffron Medicare Private Limited and 2 more | Director | 14 Feb 2019 | 7 Years 8 Months | Current |
| Aman Bansal Also directs: Grapheal Pharmaceuticals LLP | Director | 14 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Biostem Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biostem Pharma Private Limitedthis company | ₹1.65 Cr (FY 2025) | ₹3.28 Lakh | 2% | 15.0% | Shahabad Markanda, Haryana, India | |
| Rabhiaans Biotech Private Limited | ₹1.65 Cr (FY 2024) | 119.0% | Dehradur, Uttarakhand, India | |||
| Voopar Sciences Private Limited | ₹1.64 Cr (FY 2024) | 0.0% | Ambala Cantt, Haryana, India | |||
| Lift Life Biotech Private Limited | ₹1.64 Cr (FY 2025) | 37.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Biostem Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2022 | 100671599 | Hdfc Bank Limited | ₹5.5 Lakh | Open | |
| 10 Aug 2021 | 100486199 | Hdfc Bank Limited | ₹8 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Biostem Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biostem Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biostem Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICB2838G1ZR | Haryana | Active | 19 Apr 2019 |
To see the full GST registrations and return filing status of Biostem Pharma Private Limited, buy the company report.
Recent activity
Biostem Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Aman Bansal was appointed as Director on 14 Feb 2019.
AGM
Biostem Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biostem Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.50 Lakh with Charge ID 100671599 was registered on 23 Sep 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.00 Lakh with Charge ID 100486199 was registered on 10 Aug 2021.
Appointed
Aman Bansal was appointed as Director.
Appointed
Inder Jeet Singh was appointed as Director.
Incorporation
14 Feb 2019
Biostem Pharma Private Limited was registered on 14 Feb 2019 with Roc Delhi & aged 7 years 8 months as per MCA records.
Frequently asked questions
Biostem Pharma is an active private limited company based in Shahabad Markanda, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 February 2019 (7+ years old) and is registered under CIN U24290HR2019PTC078557.
Biostem Pharma has 2 current directors:
- Inder Jeet Singh - Director
- Aman Bansal - Director
The latest financial statements of Biostem Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Biostem Pharma is 06AAICB2838G1ZR, registered in Haryana.
The CIN (Corporate Identification Number) of Biostem Pharma is U24290HR2019PTC078557. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biostem Pharma was incorporated on 14 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biostem Pharma by revenue are Rabhiaans Biotech Private Limited, Voopar Sciences Private Limited, Lift Life Biotech Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Aman Bansal was appointed as Director on 14 Feb 2019. Inder Jeet Singh was appointed as Director on 14 Feb 2019.
Yes, Biostem Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0028364).
The registered office of Biostem Pharma is at H.No. 90 Sector – 1 HUDA, Shahabad Markanda, Haryana, India – 136135.
Biostem Pharma operates in the pharma industry, in the drug formulation and development segment.